Current Status
Not Enrolled
Get Started

Module Description


The goal of this session is to prepare learners to assess and manage
a woman newly diagnosed with HIV using a team-based approach.



By the end of the module, the learner will be able to:

  • Identify barriers to and describe strategies to improve linkage to care for women newly diagnosed with HIV
  • Recognize the psychosocial effects of a new HIV diagnosis
  • List risk factors related to increased risk of HIV transmission
  • Discuss appropriate antiretroviral therapy (ART) regimens for any adult
  • Describe contraception options for women living with HIV
  • Describe the appropriate clinical management and follow-up for (a) a newly diagnosed patient and (b) a stable patient with undetectable viral load (VL)

Optimizing Team-Based Care to Achieve High Quality HIV Care

Central to this module, learners should consider how they can learn to deliver care that fosters optimized team-based care to ensure high quality HIV care. As such, learners should apply themselves to the following questions:

  • How does the content of this case enable me to work within a climate of mutual respect and shared values with other health professionals?
  • How does a better understanding of my own role and those of the other professions enable me to address the needs of patients, including promoting better care for people with HIV?
  • How does this case help me optimize communication with patients, families, communities and professionals in health and other fields in a responsive and responsible manner that supports a team-based approach to care?
  • What strategies have I learned from this case that can ensure I participate effectively as a member of the health care team, recognizing the different team roles necessary to plan, deliver and evaluate patient/population-centered care, and ensure that patient care is safe, timely, efficient, effective and equitable?


AZT  Zidovudine 


CARG  Community ART refill group

CATS  Community Adolescent treatment  supporters 

CrAG  Cryptococcal antigen 

DTG  Dolutegravir 

EFV  Efavirenz

FTC  Emtricitabine

HBsAg  Hepatitis B virus surface antigen 

HIV PrEP  HIV pre-exposure prophylaxis 

IPE Interprofessional Education 

GBV  Gender-based violence 

NVP  Nevirapine

PEP Post-exposure prophylaxis

PMTCT  Prevention of mother to child transmission   of HIV 

PWH  People with HIV

RPR  Reactive plasma reagin 

TDF  Tenofovir disoproxil fumarate

 QI  Quality improvement 

SDG  Sustainable Development Goals

 U = U  Undetectable = Untransmittable 

3TC  Lamivudine